RNCP

ReAlta Life Sciences Announces New Research Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate RLS-0071 as a Medical Countermeasure for Acute Radiation Syndrome

Retrieved on: 
Thursday, March 28, 2024

“We are very pleased to partner with NIAID and AFRRI to evaluate ReAlta’s lead drug candidate, RLS-0071, as a radiation countermeasure for GI-ARS,” says Dr. Ulrich Thienel, Chief Executive Officer of ReAlta.

Key Points: 
  • “We are very pleased to partner with NIAID and AFRRI to evaluate ReAlta’s lead drug candidate, RLS-0071, as a radiation countermeasure for GI-ARS,” says Dr. Ulrich Thienel, Chief Executive Officer of ReAlta.
  • AFRRI is unique and powerful radiobiological research institute, with six decades of active, robust, and outstanding support to the U.S. Department of Defense through research, reach-back, and education.
  • It is the only U. S. Department of Defense medical R&D facility dedicated solely to nuclear and radiological defense.
  • ReAlta Life Sciences, Inc. is a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute inflammatory and rare diseases.

RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

Retrieved on: 
Tuesday, March 5, 2024

The overall evaluation will also include assessment of opaganib's efficacy against sub-chronic fibrosis and acute respiratory distress syndrome (ARDS) resulting from Sulfur Mustard exposure.

Key Points: 
  • The overall evaluation will also include assessment of opaganib's efficacy against sub-chronic fibrosis and acute respiratory distress syndrome (ARDS) resulting from Sulfur Mustard exposure.
  • "With the alarming increase in global geo-political instability, the opportunity to evaluate opaganib as a potential vital protective agent against chemical attack is inspiring.
  • "Opaganib is the first selective sphingosine kinase-2 (SPHK2) inhibitor investigational drug targeting sphingolipid metabolism to be evaluated as a chemical countermeasure.
  • Opaganib, a novel oral, small molecule pill with a five-year shelf-life, is easy to administer and distribute for use against potential chemical weapon attack, if approved by the FDA.

RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication

Retrieved on: 
Tuesday, February 20, 2024

The published data shows that opaganib2 protects against radiation-induced lung inflammation and fibrosis in an in vivo mouse model of lung damage following exposure to ionizing radiation, demonstrating its potential use as a medical countermeasure against nuclear irradiation and in cancer radiotherapy.

Key Points: 
  • The published data shows that opaganib2 protects against radiation-induced lung inflammation and fibrosis in an in vivo mouse model of lung damage following exposure to ionizing radiation, demonstrating its potential use as a medical countermeasure against nuclear irradiation and in cancer radiotherapy.
  • Radiation-induced inflammation is known to occur in two phases – in an initial inflammatory response immediately after irradiation and in a delayed response that can occur weeks later.
  • Thus, treating with opaganib during both initial and delayed phases of inflammation provided the greatest improvement in survival.
  • "These data further demonstrate that sphingolipid metabolism is a critical regulator of fibrogenesis, and specifically show that opaganib suppresses radiation-induced pulmonary inflammation and fibrosis."

Codex Labs Introduces Integrative Medical Advisory Board

Retrieved on: 
Thursday, May 25, 2023

San Jose, CA, May 25, 2023 (GLOBE NEWSWIRE) -- Codex Labs, a Silicon Valley bio-skintech company, announced an expanded medical advisory board (MAB) to support its focus on integrative skin-gut-brain solutions.

Key Points: 
  • San Jose, CA, May 25, 2023 (GLOBE NEWSWIRE) -- Codex Labs, a Silicon Valley bio-skintech company, announced an expanded medical advisory board (MAB) to support its focus on integrative skin-gut-brain solutions.
  • The Chairman of the MAB is Dr. Raja Sivamani, MD MS AP, is an integrative dermatologist, bioengineer, and Ayurvedic practitioner.
  • He is the founding director of the Chicago Integrative Eczema Center and a board member of the National Eczema Association.
  • She is also board certified in Integrative Medicine and Lifestyle Medicine, and is active on the American Board of Integrative Medicine.

New Age Programs and Prestigious European Degrees with Britts Imperial University College in UAE

Retrieved on: 
Thursday, October 27, 2022

Studying in the UAE helps one learn about many different cultures.

Key Points: 
  • Studying in the UAE helps one learn about many different cultures.
  • However, the UAE has created such conditions of life and work that nobody feels as a foreigner in this country.
  • Located in the heart of Sharjah, Britts Imperial University College offers a one-of-its-kind platform to learners from all across the globe to earn prestigious European degrees in the Middle East.
  • Britts Imperial is an Academic Centre and Education Partner of top-tier globally recognized British and European universities to offer Undergraduate, Postgraduate and Doctorate degree programs awarded by these universities.

New Age Programs and Prestigious European Degrees with Britts Imperial University College in UAE

Retrieved on: 
Thursday, October 27, 2022

Studying in the UAE helps one learn about many different cultures.

Key Points: 
  • Studying in the UAE helps one learn about many different cultures.
  • However, the UAE has created such conditions of life and work that nobody feels as a foreigner in this country.
  • Located in the heart of Sharjah, Britts Imperial University College offers a one-of-its-kind platform to learners from all across the globe to earn prestigious European degrees in the Middle East.
  • Britts Imperial is an Academic Centre and Education Partner of top-tier globally recognized British and European universities to offer Undergraduate, Postgraduate and Doctorate degree programs awarded by these universities.

Euclea Business School: Most Innovative Business School for Globalization of Management Education in the Middle East

Retrieved on: 
Tuesday, October 25, 2022

SHARJAH, UAE, Oct. 25, 2022 /PRNewswire/ -- Euclea Business School is a Private Higher Education degree-granting institution, a leader in research and education that offers a range of higher education suitable for all types of profiles and careers, with titles recognized by the State (RNCP titles) and the French Ministry of Higher Education, Research and Innovation.

Key Points: 
  • Britts Imperial University College, Sharjah is the first overseas campus of the renowned Euclea Business School based in France.
  • The university's first learning space in the Middle East opened at Sharjah Publishing City and has students from more than 40 nationalities.
  • Euclea Business School offers a wide range of undergraduate and postgraduate programs including: International Business, Digital Marketing, Human Resources, Healthcare Management, Accounting and Finance, IT Project Management, Data Analytics and AI, Logistics and Supply Chain, Events and Sports Management, Hospitality Management and many more.
  • International mobility is one of the values that Euclea Business School wishes to develop year after year and thus, understand the importance of a globally connected one world.

SKEMA and EADA Create a Double-Degree BBA in Barcelona

Retrieved on: 
Tuesday, September 28, 2021

SKEMA Business School and EADA Business School have signed an agreement to launch a new joint double-degree BBA programme "SKEMA X EADA Global BBA" in Barcelona, where EADA operates.

Key Points: 
  • SKEMA Business School and EADA Business School have signed an agreement to launch a new joint double-degree BBA programme "SKEMA X EADA Global BBA" in Barcelona, where EADA operates.
  • View the full release here: https://www.businesswire.com/news/home/20210928006004/en/
    Official signing of the partnership between SKEMA and EADA on 20 September 2021 from SKEMA Business Schools Grand Paris Campus.
  • (Photo: Business Wire)
    Through this alliance, SKEMA intends to develop a new European base from EADA's Barcelona campus.
  • "This post-baccalaureate double-degree programme is a new opportunity to develop SKEMAs brand in the European continent and South America with EADA.